Composition:
Tofacitinib Tablets 5 mg
Jakura (Tofacitinib) is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. It is approved by the FDA for treatment of moderate to severe rheumatoid arthritis that responds inadequately to methotrexate or in those who are intolerant to methotrexate.
*To be consumed as directed by physician.
